Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,218 | 21,917 | 26,428 | 29,813 | 32,494 |
| Receivables | 1,077 | 1,003 | 890 | 550 | 1,207 |
| TOTAL | $19,660 | $24,492 | $29,091 | $32,205 | $35,761 |
| Non-Current Assets | |||||
| PPE Net | 211 | 244 | 271 | 252 | 305 |
| Other Non-Current Assets | 1,702 | 1,810 | 1,897 | 157 | 213 |
| TOTAL | $1,913 | $2,054 | $2,168 | $409 | $518 |
| Total Assets | $21,573 | $26,546 | $31,259 | $32,614 | $36,279 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,403 | 2,139 | 3,022 | 1,806 | 1,421 |
| TOTAL | $2,654 | $2,379 | $3,262 | $1,924 | $1,587 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,529 | 1,582 | 1,613 | 0 | 10 |
| TOTAL | $1,529 | $1,582 | $1,613 | $N/A | $10 |
| Total Liabilities | $4,183 | $3,961 | $4,875 | $1,924 | $1,597 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,174 | 10,174 | 10,174 | 10,174 | 10,174 |
| Common Shares | 10 | 10 | 10 | 10 | 10 |
| Retained earnings | -325,213 | -319,870 | -315,914 | -311,450 | -307,285 |
| TOTAL | $17,390 | $22,585 | $26,384 | $30,690 | $34,682 |
| Total Liabilities And Equity | $21,573 | $26,546 | $31,259 | $32,614 | $36,279 |